What is the association between Ledderhose disease (plantar fibromatosis) and Dupuytren’s contracture or genetic risk factors in humans?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ledderhose Disease: Strong Association with Dupuytren's Contracture and Genetic Risk

Ledderhose disease (plantar fibromatosis) is significantly associated with Dupuytren's contracture, occurring in approximately 15% of Dupuytren's patients compared to only 4% of controls, representing a 4-fold increased risk. 1

Key Clinical Associations

Dupuytren's Contracture Connection

The relationship between Ledderhose disease and Dupuytren's contracture is well-established and clinically significant:

  • Men with Dupuytren's disease have 4.35 times higher odds of developing Ledderhose disease (95% CI: 1.3-16.7) 1
  • The association is strongest in patients with advanced Dupuytren's disease—those requiring surgery or presenting with finger contractures have 6.1 times higher odds of plantar nodules compared to those with only palmar nodules 1
  • Family history of Dupuytren's disease increases Ledderhose risk 3-fold (OR = 3.1,95% CI: 1.1-8.5) 1

Part of a Broader Fibromatosis Spectrum

Ledderhose disease belongs to a family of related fibroproliferative disorders 2, 3:

  • Dupuytren's contracture (palmar fibromatosis)
  • Peyronie's disease (penile fibromatosis)
  • Knuckle pads (dorsal digital fibromatosis)

When knuckle pads are present, there is a statistically significant association with both Ledderhose and Peyronie's diseases (P < 0.001) 4. Microscopic examination confirms these conditions share identical cell types and extracellular matrix composition 4.

Genetic Risk Factors

Dupuytren Diathesis Features

Patients with certain clinical characteristics carry significantly more genetic risk alleles:

  • Age of onset < 50 years
  • Positive family history
  • Knuckle pads (strongest genetic association)
  • Ledderhose disease

Patients presenting with knuckle pads are most likely to carry multiple risk alleles for the identified Dupuytren's disease single nucleotide polymorphisms (SNPs) 5. Nine specific SNPs have been identified that can calculate a weighted genetic risk score for this disease spectrum 5.

Clinical Implications

Screening Recommendations

When examining patients with Dupuytren's contracture, specifically assess for:

  • Bilateral parotid gland hypertrophy
  • Muscle wasting and malnutrition
  • Dupuytren's contracture itself
  • Gynecomastia
  • Extensive spider naevi

These signs suggest harmful alcohol consumption, which is a recognized risk factor for fibromatosis 2.

Surgical Considerations

Patients with diagnoses of Dupuytren's, Ledderhose, or Peyronie's diseases have significantly increased risk of arthrofibrosis following total knee arthroplasty 6:

  • Higher rates of ankylosis at 30 days (OR 1.54 for Dupuytren's, OR 1.23 for Ledderhose)
  • Increased need for manipulation under anesthesia at 90 days, 6 months, and 1 year
  • This association persists through 1-year follow-up

Common Pitfall: Failing to recognize this increased fibroproliferative tendency in surgical planning. These patients require more aggressive post-operative physical therapy and closer monitoring for contracture development.

Pathophysiology

The conditions share common histopathological features based on proliferation of collagen and fibroblasts 3. While etiology remains incompletely understood, associations include:

  • Trauma
  • Diabetes mellitus
  • Anticonvulsant use
  • Frozen shoulder
  • Alcohol consumption
  • Liver disease

The genetic basis involves common DNA polymorphisms rather than rare variants, creating a disadvantaged profile toward fibroproliferative disease susceptibility 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.